Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens-Reference-Cited by-同舟云学术

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

Published:2018-10-24 Issue:2 Volume:173 Page:397-406
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Cabel Luc^ORCID,Carton Matthieu,Cheaib Bianca,Pierga Jean-Yves,Dalenc Florence,Mailliez Audrey,Levy Christelle,Jacot William,Debled Marc,Leheurteur Marianne,Desmoulins Isabelle,Lefeuvre Claudia,Gonçalves Anthony,Uwer Lionel,Ferrero Jean-Marc,Eymard Jean-Christophe,Petit Thierry,Mouret-Reynier Marie-Ange,Perrocheau Geneviève,Piot Irwin,Pérol David,Simon Gaëtane,Lerebours Florence

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-5017-2/fulltext.html

Reference31 articles.

1. Cardoso F, Senkus E, Costa A et al (2018) 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†. Ann Oncol 29:1634–1657. https://doi.org/10.1093/annonc/mdy192

2. Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262

3. Pusztai L, Walters RS, Valero V et al (1998) Daily oral etoposide in patients with heavily pretreated metastatic breast cancer. Am J Clin Oncol 21:442–446

4. Atienza DM, Vogel CL, Trock B, Swain SM (1995) Phase II study of oral etoposide for patients with advanced breast cancer. Cancer 76:2485–2490

5. Nesković-Konstantinović ZB, Bosnjak SM, Radulović SS, Mitrović LB (1996) Daily oral etoposide in metastatic breast cancer. Anticancer Drugs 7:543–547

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversal of the tamoxifen‑resistant breast cancer malignant phenotype by proliferation inhibition with bromosulfonamidine amino‑podophyllotoxin;Oncology Letters;2024-06-13

2. Three-dimensional cell cultures as preclinical models to assess the biological activity of phytochemicals in breast cancer;Toxicology and Applied Pharmacology;2023-02

3. Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals;Cancers;2022-04-24

4. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort;The Breast;2020-08

5. Excellent Response to Oral Etoposide in HER2-Positive Metastatic Breast Cancer (MBC);Indian Journal of Gynecologic Oncology;2019-07-25